| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 16 |
| Opened positions | 3 |
| Closed positions | 0 |
| Increased positions | 2 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 3.50 bn |
| Total shares | 44.43 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Panacea Innovation | 13.41 mm | $17.17 mm |
| BioFortune | 6.16 mm | $6.90 mm |
| Huang James | 6.00 mm | $6.00 mm |
| Shanghai Minhui Enterprise Management Consulting Partnership | 5.31 mm | $0.00 |
| Advantech Capital II | 4.76 mm | $24.53 mm |
| Qiming Venture Partners V | 3.20 mm | $0.00 |
| Qiming Venture Partners VII | 3.20 mm | $16.47 mm |
| BML Capital Management | 2.09 mm | $3.01 bn |
| Renaissance Technologies | 175.50 k | $252.70 mm |
| Callan Capital | 41.82 k | $60.22 mm |
